Regional Pilot Program in partnership with MD Anderson Cancer Center, an NCI Designated Cancer Center
June 14, 2013
MD Anderson Cancer Center
Houston, TX
Click on the session title to view the corresponding slides. |
Presentations included allotted time for Audience Response System (ARS) assisted audience interaction as well as general question and answer time for the presenter. |
|
7:00 am - 8:00 am | Registration |
7:00 am - 8:00 am | Breakfast |
8:00 am - 8:05 am | Welcome and Introductions Elizabeth A. Mittendorf, MD, PhD - MD Anderson Cancer Center |
8:05 am - 9:00 am | Basic Immunology Kimberly S. Schluns, PhD - MD Anderson Cancer Center |
9:00 am - 9:30 am | Innate Immunity Willem W. Overwijk, PhD - MD Anderson Cancer Center |
9:30 am - 9:45 am | Break |
9:45 am - 10:15 am | Tumor Microenvironment Thomas F. Gajewski, MD, PhD - University of Chicago |
10:15 am - 10:55 am | Therapeutic Cancer Vaccines & Cytokines Elizabeth A. Mittendorf, MD, PhD - MD Anderson Cancer Center |
10:55 am - 11:30 am | Adoptive T Cell Transfer Patrick Hwu, MD - MD Anderson Cancer Center |
11:30 am - 12:00 pm | Panel Discussion |
12:00 pm - 12:45 pm | Lunch |
12:45 pm - 1:20 pm | Checkpoint Blockade James P. Allison, PhD - MD Anderson Cancer Center |
1:20 pm - 1:50 pm | Combination Therapies Michael A. Curran, PhD - MD Anderson Cancer Center |
1:50 pm - 2:25 pm | Current Immunotherapies and Immunemonitoring Padmanee Sharma, MD, PhD - MD Anderson Cancer Center |
2:25 pm - 2:55 pm | Panel Discussion |
2:55 pm - 3:00 pm | Closing Remarks Patrick Hwu, MD - MD Anderson Cancer Center |
All presentations are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.